THOMPSON DAVIS & CO., INC. - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 71 filers reported holding DURATA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$3,0000.0%2500.0%0.00%
-20.0%
Q1 2014$3,0002500.01%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 508,472$4,596,0003.19%
Broadfin Capital, LLC 383,227$3,464,0000.62%
Orbimed Advisors 1,785,714$16,143,0000.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,979$2,495,0000.12%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 1,188,571$10,745,0000.10%
Lenox Wealth Advisors, LLC 8,000$72,0000.07%
STONERIDGE INVESTMENT PARTNERS LLC 30,732$278,0000.06%
Loeb Offshore Management LP 19,621$177,0000.06%
Alyeska Investment Group, L.P. 100,000$904,0000.04%
PARADIGM ASSET MANAGEMENT CO LLC 25,000$226,000,0000.04%
View complete list of DURATA THERAPEUTICS INC shareholders